These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5576831)

  • 21. [Treatment of Parkinson's disease by L-DOPA].
    Barbeau A
    Union Med Can; 1969 Feb; 98(2):183-6. PubMed ID: 5773394
    [No Abstract]   [Full Text] [Related]  

  • 22. [L-dopa and bronchial asthma. Preliminary report].
    Ingvarsson G
    Nord Med; 1965 Nov; 74(46):1166-7. PubMed ID: 5848120
    [No Abstract]   [Full Text] [Related]  

  • 23. Insights into creation and use of prescribing documentation in the hospital medical record.
    Tully MP; Cantrill JA
    J Eval Clin Pract; 2005 Oct; 11(5):430-7. PubMed ID: 16164583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of L-DOPA on the akinesis in Parkinson's syndrome].
    Bischoff A
    Schweiz Med Wochenschr; 1967 Sep; 97(35):1158-9. PubMed ID: 5593650
    [No Abstract]   [Full Text] [Related]  

  • 25. [Preliminary observations on the use of L-DOPA in the treatment of the akinetic symptoms of Parkinson's disease].
    Uriciuoli R; Nivoli GC
    Minerva Med; 1968 May; 59(43):2516-21. PubMed ID: 5664430
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term impact of the women's health initiative on HRT.
    Parente L; Uyehara C; Larsen W; Whitcomb B; Farley J
    Arch Gynecol Obstet; 2008 Mar; 277(3):219-24. PubMed ID: 17713777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Action of L-DOPA on the extrapyramidal symptomatology of haloperidol].
    Bruno A; Brigida E
    Riv Neurobiol; 1965; 11(4):646-54. PubMed ID: 5888019
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the treatment of Parkinson's syndrome with monoamine oxidase inhibitors alone and in combination with L-dopa].
    Gerstenbrand F; Prosenz P
    Praxis; 1965 Nov; 54(46):1373-7. PubMed ID: 5899418
    [No Abstract]   [Full Text] [Related]  

  • 29. [L-DOPA therapy of parkinsonism].
    Refsum S
    Nord Med; 1969 May; 81(18):570-1. PubMed ID: 5768311
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescribing trends in internal medicine.
    Uppal R; Nayak P; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):375-6. PubMed ID: 6469426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary observations on L-dopa in the treatment of Parkinson's disease.
    Jelsma F; Roth R; Ross P; Davis J
    J Ky Med Assoc; 1971 Apr; 69(4):265-9. PubMed ID: 5577419
    [No Abstract]   [Full Text] [Related]  

  • 32. [Orientative clinical trials on the effects of dihydroxyphenylalanine (1-dopa) in endogenous depression].
    Ingvarsson CG
    Arzneimittelforschung; 1965 Aug; 15(8):849-52. PubMed ID: 5898634
    [No Abstract]   [Full Text] [Related]  

  • 33. Prescribing non-psychopharmacological agents: a new potential role for psychologists in primary care settings and specialty clinics.
    Earles JE; James LC; Folen RA
    J Clin Psychol; 2006 Oct; 62(10):1213-20. PubMed ID: 16897696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A synergistic neurotrophic response to l-dihydroxyphenylalanine and nerve growth factor.
    Mena MA; Davila V; Bogaluvsky J; Sulzer D
    Mol Pharmacol; 1998 Oct; 54(4):678-86. PubMed ID: 9765511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys.
    Hsu A; Togasaki DM; Bezard E; Sokoloff P; Langston JW; Di Monte DA; Quik M
    J Pharmacol Exp Ther; 2004 Nov; 311(2):770-7. PubMed ID: 15226382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does legislation reduce harm to doctors who prescribe for themselves?
    Kay M; Del Mar CB; Mitchell G
    Aust Fam Physician; 2005; 34(1-2):94-6. PubMed ID: 15727371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [[Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report].
    Fritze J
    Nervenarzt; 2008 Nov; 79(11):1337-45. PubMed ID: 19002733
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prescriptions for psychotropic drugs: results and comments on the 2005 prescription drug report].
    Fritze J
    Nervenarzt; 2006 Mar; 77(3):376-83. PubMed ID: 17078120
    [No Abstract]   [Full Text] [Related]  

  • 39. [Modification of the prescribing practice of the physician by legislation with special reference to non-approved drugs].
    Bergmann KO
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):610-6. PubMed ID: 9527452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical audit activity. Prescribing for common conditions--hypertension.
    Mant A
    Aust Fam Physician; 1999 Apr; 28(4):361-2; quiz 363-4. PubMed ID: 10330762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.